Cargando…
Confirmation of neurometabolic diagnoses using age‐dependent cerebrospinal fluid metabolomic profiles
Timely diagnosis is essential for patients with neurometabolic disorders to enable targeted treatment. Next‐Generation Metabolic Screening (NGMS) allows for simultaneous screening of multiple diseases and yields a holistic view of disturbed metabolic pathways. We applied this technique to define a c...
Autores principales: | Peters, Tessa M. A., Engelke, Udo F. H., de Boer, Siebolt, van der Heeft, Ed, Pritsch, Cynthia, Kulkarni, Purva, Wevers, Ron A., Willemsen, Michèl A. A. P., Verbeek, Marcel M., Coene, Karlien L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540372/ https://www.ncbi.nlm.nih.gov/pubmed/32406085 http://dx.doi.org/10.1002/jimd.12253 |
Ejemplares similares
-
Variable Selection in Untargeted Metabolomics and the Danger of Sparsity
por: Tinnevelt, Gerjen H., et al.
Publicado: (2020) -
Novel cerebrospinal fluid biomarkers of glucose transporter type 1 deficiency syndrome: Implications beyond the brain's energy deficit
por: Peters, Tessa M. A., et al.
Publicado: (2022) -
Application of metabolite set enrichment analysis on untargeted metabolomics data prioritises relevant pathways and detects novel biomarkers for inherited metabolic disorders
por: Hoegen, Brechtje, et al.
Publicado: (2022) -
Amadori rearrangement products as potential biomarkers for inborn errors of amino-acid metabolism
por: van Outersterp, Rianne E., et al.
Publicado: (2021) -
Monoamine oxidase A activity in fibroblasts as a functional confirmation of MAOA variants
por: Peters, Tessa M. A., et al.
Publicado: (2020)